A double blinded, comparator controlled, randomized single center clinical study to evaluate the safety and efficacy of facial bleach formulations in improving and retaining skin fairness on healthy human subjects

Dabur India Ltd0 个研究点目标入组 220 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.220 female & Male subjects in generally good health.
•2.Subjects in 18 to 34 years of age group.
•3.Subjects must have used facial bleach at least once.
•4.Subjects with clear face without any age/dark spots.
•5.Subjects having Chromameter reading in the range of 50.00-61.00 as average of cheeks, forehead and chin.
•6.Out of 160 subjects, 40 with Most Sensitive Skin.
•7.Out of 160 subjects, 40 with young and sensitive Skin.
•8.Out of 160 subjects, 20 with wheatish Skin Complexion.
•9.Out of 160 subjects, 40 with Fairer Skin Complexion.
•10.Out of 160 subjects, 20 male subjects.
•11.Subjects willing to give a written informed consent and come for regular follow up.

•1.Subjects with known allergies or sensitivities to cosmetic products, toiletries or its components like fragrances, preservatives, hydroquinone, vitamin C, Niacin amide, retinol, soy etc.
•2.Currently or has been using topical retinoids, alpha-hydroxy and/or beta-hydroxy acids, hydroquinone or any whitening/Fairness preparation in any form (cleanser, toner, facial lotion, cream or soaps) within the last 1 month.
•3.Currently or has been undergoing dermatologist facial treatments or procedures within the last 1 month.
•4.Currently or has been involved in another facial skin care clinical investigation within the last 3 months.
•5.Subjects who have pre-existing or dormant facial dermatologic conditions (e.g., psoriasis, rosacea, rashes, eczema, many and/or severe excoriations etc.) that could interfere with the outcome of the study as determined by the investigator.
•6.Subjects who have a medical history of disease or condition or a concurrent illness that could affect the outcome of the study.
•7.Subjects with excessive facial hair or scars (including acne scars), which could interfere with expert grader and/or instrumental evaluations.

发起方